OSR Holdings Inc
OSR Holdings Inc is a biotechnology company focused on healthcare diagnostics, primarily generating revenue through the development and commercialization of diagnostic products and services.
Business. OSR Holdings Inc (OSRH.O) is a healthcare diagnostics company operating within the biotechnology and medical research industry. The firm is headquartered in the United States and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Osr Holdings Inc (OSRH.O) has recorded two notable additions to its shareholder base, marking the first analysis for this ticker. As of the most recent data, the company has no analyst coverage, no index memberships, and no reported officers, with a total of three top holders identified. The first significant change involves investor ID 465, who added a position of 54,402 shares as of December 31, 2025. This holding represents a value of $0.030682 million and constitutes a weight of approximately 4.45e-07 percent of the total shares. A second notable addition was made by investor ID 499, who acquired 4,476 shares as of March 31, 2026. This position is valued at $0.002699 million, representing a weight of approximately 4.79e-07 percent. These changes are significant as they represent the initial baseline for tracking institutional or significant holder activity for OSRH.O. With no prior basis for delta computation, these entries establish the starting point for monitoring future shifts in ownership structure for the company.
Signals & dispatch
Composite-score breakdown
Synthesis
OSR Holdings Inc (OSRH.O) is a healthcare diagnostics company operating within the biotechnology and medical research industry. The firm is headquartered in the United States and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
OSR Holdings Inc exhibits a highly leveraged capital structure with a debt-to-equity ratio of 0.06, indicating minimal reliance on debt financing. However, the company's liquidity position is weak, as evidenced by a current ratio of 0.16, suggesting significant short-term liquidity constraints. The price-to-book ratio of 0.27 and price-to-tangible-book ratio of 0.27 further indicate that the company's market value is significantly below its book value, reflecting poor investor sentiment or asset impairment.
Profitability metrics are severely negative, with a return on equity of -0.232 and a return on assets of -0.1052, both well below industry norms. The company reported a net loss of $18.01 million and an operating loss of $18.34 million, indicating a lack of operational efficiency and revenue generation. Gross profit of $592,910 is minimal relative to total revenue of $2.91 million, suggesting high cost structures or low pricing power.
Geographically and segment-wise, OSR Holdings Inc's revenue concentration is not disclosed in the available data. However, the company's exposure to the healthcare diagnostics industry implies a high degree of specialization, with potential risks tied to regulatory changes and technological obsolescence. The absence of detailed segment reporting limits the ability to assess diversification or growth drivers within the business.
The company's growth trajectory is negative, with no clear signs of improvement in the near term. Analysts have assigned a mean price target of $10.00, which is significantly higher than the current market price of $0.64, but the lack of strong buy recommendations (0) and the presence of only one buy recommendation suggest limited confidence in the company's ability to deliver returns. The operating cash flow of -$4.33 million and free cash flow of -$17.93 million indicate a cash burn rate that could threaten the company's solvency if not addressed.
Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is currently low, but the company's capital structure and financial performance suggest a potential need for equity financing in the future, which could dilute existing shareholders. The absence of capital expenditures and the negative operating cash flow further underscore the company's financial instability.
Recent events, including the lack of positive analyst sentiment and the absence of disclosed capital expenditures, suggest a challenging operating environment. The company's financial performance and risk profile indicate a need for significant operational and strategic improvements to restore investor confidence and achieve profitability.
Osr Holdings Inc (OSRH.O) has recorded two notable additions to its shareholder base, marking the first analysis for this ticker. As of the most recent data, the company has no analyst coverage, no index memberships, and no reported officers, with a total of three top holders identified. The first significant change involves investor ID 465, who added a position of 54,402 shares as of December 31, 2025. This holding represents a value of $0.030682 million and constitutes a weight of approximately 4.45e-07 percent of the total shares. A second notable addition was made by investor ID 499, who acquired 4,476 shares as of March 31, 2026. This position is valued at $0.002699 million, representing a weight of approximately 4.79e-07 percent. These changes are significant as they represent the initial baseline for tracking institutional or significant holder activity for OSRH.O. With no prior basis for delta computation, these entries establish the starting point for monitoring future shifts in ownership structure for the company.
- OSR Holdings Inc is operating at a significant loss, with a net loss of $18.01 million and an operating loss of $18.34 million.
- The company's liquidity position is weak, with a current ratio of 0.16 and a negative net cash position.
- Profitability metrics are severely negative, with a return on equity of -0.232 and a return on assets of -0.1052.
- Analysts have assigned a mean price target of $10.00, but the lack of strong buy recommendations suggests limited confidence in the company's future performance.
- The company's capital structure and financial performance indicate a potential need for equity financing, which could dilute existing shareholders.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- OSR Holdings Inc Market data — financials · 2026-05-28
- OSR Holdings Inc Market data — analyst estimates · 2026-05-28
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$0M
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 38.0%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -134.0%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): -17.7%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 97.6%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): -26.9%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -14.9%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 83.3%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 80.8%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -2.3%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -56.8%Derived (calculated)
- Gross margin (FY 2025-12-31): 20.4%Derived (calculated)
- Current ratio (FY 2025-12-31): 0.16xDerived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 397.8%Derived (calculated)
- Revenue (annual): USD 2.91MSEC XBRL filing
- Gross profit (annual): USD 592.9KSEC XBRL filing
- Total assets (annual): USD 171.24MSEC XBRL filing
- Operating cash flow (annual): USD -4.33MSEC XBRL filing
- Shares outstanding (annual): 26.6MSEC XBRL filing
- Current assets (annual): USD 2.82MSEC XBRL filing
- Current liabilities (annual): USD 17.17MSEC XBRL filing
- R&D expense (annual): USD 318.45KSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -1SEC XBRL filing
- Operating income (annual): USD -18.34MSEC XBRL filing
- Pre-tax income (annual): USD -28.89MSEC XBRL filing